NSABP PROTOCOL B-31 A RANDOMIZED TRIAL COMPARING THE SAFETY AND EFFICACY OF ADRIAMYCIN AND CYCLOPHOSPHAMIDE FOLLOWED BY TAXOL (AC?T) TO THAT OF ADRIAMYCIN AND CYCLOPHOSPHAMIDE FOLLOWED BY TAXOL PLUS HERCEPTIN (AC?T + H) IN NODE-POSITIVE BREAST CANCER PATIENT WHO HAVE TUMORS THAT OVEREXPRESS HER2
Kathy Miller, MD
Primary Investigator
Jessica MacLean
Primary Investigator
Overview
This study is ongoing, but not recruiting participants. Subjects have completed all research-related interventions. Currently, remaining participants are in long-term follow-up. Annual response/survival data are still being collected, therefore IRB approval is necessary. It is unknown when the study will fully complete.
Description
This study is ongoing, but not recruiting participants. Subjects have completed all research-related interventions. Currently, remaining participants are in long-term follow-up. Annual response/survival data are still being collected, therefore IRB approval is necessary. It is unknown when the study will fully complete.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
breast cancer
-
Age: - 100 Years
-
Gender: All
